Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.36 |
| ▸ | LPL | P06858 | 3/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.30 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22135397 | 0.85 | ALOX5 (0.39) | LIPGLPLGPR3ALDH1A1MAPT | |
| SCHEMBL25132335 | 0.83 | LIPG (0.46) | LIPGLPLPIM3 | |
| SCHEMBL27451759 | 0.83 | LIPG (0.46) | LIPGLPLPIM3 | |
| SCHEMBL24786947 | 0.83 | LIPG (0.37) | LIPGLPL | |
| SCHEMBL21218802 | 0.83 | — | — | |
| SCHEMBL22073709 | 0.81 | LPL (0.42) | LIPGLPL | |
| SCHEMBL16597879 | 0.80 | LIPG (0.48) | LIPGLPLGPR3ALDH1A1MAPT | |
| SCHEMBL18164688 | 0.80 | LIPG (0.58) | LIPGLPLGPR3PIM3 | |
| SCHEMBL17856777 | 0.80 | LIPG (0.58) | LIPGLPLGPR3PIM3 | |
| SCHEMBL18820583 | 0.80 | LPL (0.36) | LIPGLPLALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10957857-B2 | Multicyclic compound and organic light emitting device including the same | LG CHEM LTD. (KR) | 2021-03-23 | — | — | US | disclosed |
| EP-3476833-B1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-10-14 | — | — | EP | disclosed |
| US-20190237674-A1 | MULTICYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME (AS AMENDED) | LG CHEM, LTD. (KR) | 2019-08-01 | — | — | US | disclosed |
| EP-3476833-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2019-05-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237674-A1 | MULTICYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME (AS AMENDED) | CRY1, MT-CO1, PER2 | LIPG 3656/4885LPL 2272/4885GPR3 4232/4885 |
| US-10957857-B2 | Multicyclic compound and organic light emitting device including the same | CRY1, CYP1A1, TMEM109 | LIPG 3182/4885LPL 2381/4885GPR3 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.